European Archives - Page 9 of 1191 - European Medical Journal

MOv18 IgE and Non-Allergic Skin Reactions in AllergoOncology

MOv18 IgE is a first-in-class IgE antibody targeting FRα, an antigen overexpressed in ovarian and other cancers…

Review of the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025

THIS SUMMER, the welcoming city of Glasgow, UK, proudly hosted the EAACI Congress 2025, a pivotal event that brought together…

Predicting Psoriatic Arthritis in Early Psoriasis

Early intervention in psoriatic arthritis (PsA) is disease-modifying, and delays in diagnosis, even by 6 months, can reduce treatment…

EMJ Allergy & Immunology 10.1 2025

Including our independent review of the EAACI Congress 2025, as well as an exclusive interview with the EAACI President…

EMJ's Latest Rheumatology Journal

Discover what’s new in Rheumatology in our new issue, featuring coverage on psoriatic arthritis and axial spondyloarthritis, giant cell…

Review of the European Alliance of Associations for Rheumatology (EULAR) 2025 Congress

THE EUROPEAN Alliance of Associations for Rheumatology (EULAR) 2025 Congress, the most dynamic event of the year for the rheumatology…

24 Jul 2025

Navigating Head and Neck Atopic Dermatitis

This ICS highlights key symptoms, diagnostic features, and evolving treatment approaches, including the use of tralokinumab…

Bridging HAE Treatment Gaps

Hereditary angioedema (HAE) attacks are unpredictable and can be debilitating and potentially life-threatening. The burden of HAE disease…

EMJ's Latest Allergy & Immunology Journal

Uncover the latest from EAACI and beyond in our new publication, including interviews with industry experts, insights on the early…

Updates on Chronic Spontaneous Urticaria: EAACI 2025

CHRONIC spontaneous urticaria (CSU) was a key focus at the EAACI Congress 2025 in Glasgow, UK, reflecting a growing momentum in the search…